Det Sundhedsfaglige Børneteam - Støtte ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 7.0% 6.0% 6.0% 3.3%  
Credit score (0-100)  0 36 40 39 53  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Gross profit  0.0 506 278 1,362 4,666  
EBITDA  0.0 506 262 130 1,014  
EBIT  0.0 506 262 130 1,014  
Pre-tax profit (PTP)  0.0 506.0 265.0 127.3 1,013.4  
Net earnings  0.0 393.6 206.7 99.3 790.3  
Pre-tax profit without non-rec. items  0.0 506 265 127 1,013  

 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 444 300 400 1,190  
Interest-bearing liabilities  0.0 0.0 45.3 106 28.0  
Balance sheet total (assets)  0.0 992 446 1,088 1,859  

Net Debt  0.0 -757 -369 -291 -832  
 
See the entire balance sheet

Volume 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 506 278 1,362 4,666  
Gross profit growth  0.0% 0.0% -45.1% 390.1% 242.5%  
Employees  0 1 1 3 9  
Employee growth %  0.0% 0.0% 0.0% 200.0% 200.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 992 446 1,088 1,859  
Balance sheet change%  0.0% 0.0% -55.0% 143.6% 70.9%  
Added value  0.0 505.9 261.9 129.7 1,014.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 94.2% 9.5% 21.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 51.0% 36.8% 16.9% 68.8%  
ROI %  0.0% 114.1% 67.2% 30.5% 117.7%  
ROE %  0.0% 88.7% 55.6% 28.4% 99.4%  

Solidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  0.0% 44.7% 67.3% 36.7% 64.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -149.6% -141.0% -224.2% -82.0%  
Gearing %  0.0% 0.0% 15.1% 26.5% 2.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 3.2% 1.3%  

Liquidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  0.0 1.8 3.1 1.6 2.8  
Current Ratio  0.0 1.8 3.1 1.6 2.8  
Cash and cash equivalent  0.0 756.7 414.5 396.8 859.8  

Capital use efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 443.6 300.3 399.7 1,190.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 506 262 43 113  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 506 262 43 113  
EBIT / employee  0 506 262 43 113  
Net earnings / employee  0 394 207 33 88